Eurand to Present at Deutsche Bank Securities Health Care Conference
April 20 2010 - 8:00AM
Marketwired
Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical
company, announced today that Gearoid Faherty, Chairman and Chief
Executive Officer, is scheduled to present at the Deutsche Bank
Securities 35th Annual Health Care Conference. Details are as
follows:
Date: Tuesday, May 4, 2010
Time: 10:40 a.m. ET
Place: InterContinental Boston
510 Atlantic Avenue
Boston, Mass.
A live audio webcast of the presentation can be accessed in the
investor relations section of Eurand's web site at www.eurand.com
and will be available via replay for 30 days.
About Eurand
Eurand is a specialty pharmaceutical company that develops,
manufactures and commercializes enhanced pharmaceutical and
biopharmaceutical products based on its proprietary pharmaceutical
technologies. Eurand has had six products approved by the FDA since
2001 and has a pipeline of product candidates in development for
itself and its collaboration partners. Its technology platforms
include bioavailability enhancement of poorly soluble drugs, custom
release profiles and taste-masking orally disintegrating tablet
(ODT) formulations. Eurand is a global company with facilities in
the U.S. and Europe. For more information, visit
www.eurand.com.
Contacts: Bill Newbould Vice President, Investor Relations
Eurand N.V. +1 267-759-9335 Email Contact Nick Laudico/Sara
Pellegrino The Ruth Group +1 646-536-7030/7002 Email Contact Email
Contact
Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Eurand N.V. (MM) (NASDAQ:EURX)
Historical Stock Chart
From Jul 2023 to Jul 2024